Inhibition of Candida parapsilosis mitochondrial respiratory pathways enhances susceptibility to caspofungin

Area of Science:

• Mycology
• Antifungal Drug Resistance
• Mitochondrial Biology

Background:

• Candida parapsilosis exhibits a distinct mitochondrial respiratory network.
• Understanding resistance mechanisms is crucial for effective antifungal therapy.
• High minimum inhibitory concentrations (MICs) of caspofungin are a clinical concern.

Purpose of the Study:

• To investigate the impact of mitochondrial respiratory pathway inhibitors on caspofungin and fluconazole resistance in Candida parapsilosis.
• To explore the role of the unique mitochondrial network in antifungal susceptibility.

Main Methods:

• Utilized three clinical isolates of Candida parapsilosis with high caspofungin MICs (≥2 μg/mL).
• Administered inhibitors targeting mitochondrial respiratory pathways.
• Assessed changes in caspofungin and fluconazole MICs post-treatment.

Main Results:

• Inhibitors of respiratory pathways caused a significant fivefold decrease in caspofungin MICs.
• Fluconazole MICs remained unchanged despite the addition of respiratory inhibitors.
• Demonstrated a specific interaction between mitochondrial function and caspofungin efficacy.

Conclusions:

• Mitochondrial respiratory pathways are implicated in caspofungin resistance in Candida parapsilosis.
• Targeting mitochondrial respiration presents a potential strategy to overcome caspofungin resistance.
• This study highlights the importance of the mitochondrial network in antifungal drug response.